Events

Richmond Pharmacology is a frequent contributor and recognised thought leader for various scientific meetings worldwide. See below for a list of past and upcoming events.

On Helix, Transforming new medicine discovery

Event Date:
13-14 July 2020
Location:
Digital

Richmond Pharmacology will be showcasing a presentation on Adaptive Early Phase Clinical Trials as part of the ON HELIX digital event.

View Event

Cardiac Safety London

Event Date:
Wednesday 20th May 2020 - 10am – 3.30pm BST
Location:
Online Event

To help to enrich and speeding up your drug development programs, join us for a day of discovery as global experts in Cardiology, Pharmacology and Diabetes discuss the latest state of the art methods...

View Event

Clinical Trails Europe – Barcelona

Event Date:
19th -21st November
Location:
Barcelona

Partnerships, Outsourcing, Operations, and Technology event for the global clinical trials industry. Dr Jorg Taubel will be presenting on Harnessing innovation to accelerate progress for phase I to phase IIa clinical trials in the Early Clinical Development Stream on Tuesday 19th at 16.50.

View Event

The 40th Annual Scientific Meeting of The Japanese Society of Clinical Pharmacology and Therapeutics

Event Date:
4th – 6th December 2019
Location:
Tokyo

The Japanese Society of Clinical Pharmacology and Therapeutics annual event. Dr. Jorg Taubel will be presenting our latest scientific poster publication on Friday 6th.

View Event

Pharmacology 2019 by British Pharmacological Society

Event Date:
15th – 17th December
Location:
Edinburgh, UK

British Pharmacological Society’s flagship annual meeting. Dr. Richard Francis-Sakai will be presenting our latest scientific research and Richmond Pharmacology will also be exhibiting in the career zone at the event. Event Agenda Click here to view the agender/schedule

View Event

Bio Japan – 9–11 Oct, 2019

Event Date:
9th - 11th October 2019
Location:
Pacifico Yokohama, Japan

Bio Japan – 9–11 Oct, 2019 Pacifico Yokohama, Japan Richmond Pharmacology will be attending Asia’s Premier Partnering Event for the Global Biotechnology Industry. Please Visit – https://www.ics-expo.jp/biojapan/en/ For more details

View Event

Translating London scientific excellence into global therapeutic strategies

Event Date:
Tuesday 10th September 2019 at 08:00
Location:
British Residence Boston

A Department of International Trade – Life Sciences Event The event will focus on innovative early drug development opportunities in London, the South East and the broader United Kingdom With support from the British Embassy in Boston and New York, Richmond Pharmacology will be holding an event to showcase how London’s unique Life sciences environment …

View Event

Contemporary Imaging in Early Phase Clinical Trials

Event Date:
Thursday 4th July - Breakfast Event 9am -11am (Doors Open 8.30)
Location:
Glaziers Hall, 9 Montague Cl, London SE1 9DD

Richmond Pharmacology will be holding an event to show how the effective use of Contemporary Imaging and a pragmatic regulatory and commercial environment, combined with cutting edge innovative study designs can help you drive your early stage clinical programs forward and maximise information obtained, supporting optimised global development. The event will focus on Contemporary Imaging …

View Event

BIO INTERNATIONAL CONVENTION

Event Date:
3-6 June 2019
Location:
Philadelphia, PA

Richmond Pharmacology will be in attendance at the BIO INTERNATIONAL CONVENTION. The convention will be held from 3-6 June in Philadelphia, PA.

View Event

EUFEMED 2019

Event Date:
15-17 May
Location:
Lyon Conference, France,

The Changing Landscape of Early Medicines Development: Be Prepared! Lyon Conference, France, 15-17 May

View Event

Latest news

Upcoming Event

On Helix, Transforming new medicine discovery

13-14 July 2020
Richmond Pharmacology will be showcasing a presentation on Adaptive Early Phase Clinical Trials as part of the ON HELIX digital event.
View event

COVID-19 – External Monitoring Guidelines

July 1, 2020
Richmond Pharmacology is constantly assessing health and safety risks posed by COVID-19 and is regularly reviewing Public Health England guidance.
Read more

First transdermal patch to treat schizophrenia hits market

March 18, 2020
The US Food and Drug Administration (FDA) has officially approved a transdermal patch to treat schizophrenia developed by Hisamitsu Pharmaceutical Co following successful
Read more

Statement: COVID-19

March 23, 2020
Richmond Pharmacology are continuously risk-assessing our activity in relation to the COVID-19 crisis and we are evaluating what activity can continue, what precautions need to be put in place and what needs to be suspended.
Read more